Performance evaluation of the Verigene® Clostridium difficile nucleic acid test, an automated multiplex molecular testing system for detection of C. difficile toxin

被引:16
作者
Kosai, Kosuke [1 ]
Iwanaga, Yuki [1 ]
Akamatsu, Norihiko [1 ]
Okada, Yuya [1 ]
Kaku, Norihito [2 ]
Uno, Naoki [2 ]
Morinaga, Yoshitomo [2 ]
Hasegawa, Hiroo [1 ]
Miyazaki, Taiga [3 ]
Izumikawa, Koichi [3 ]
Mukae, Hiroshi [4 ]
Yanagihara, Katsunori [2 ]
机构
[1] Nagasaki Univ Hosp, Dept Lab Med, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Infect Dis, Nagasaki, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Med, Nagasaki, Japan
关键词
Microarray; Molecular diagnosis; Multiplex assay; EIA; C. difficile toxins; PCR RIBOTYPE 027; GLUTAMATE-DEHYDROGENASE; INFECTION; JAPAN; DIAGNOSIS; COLITIS; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; COLECTOMY;
D O I
10.1016/j.jiac.2017.07.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Verigene (R) Clostridium difficile nucleic acid test (Verigene (R) CDF test) is an automatic and rapid detection system for the genes encoding tcdA, tcdB, binary toxin, and the single nucleotide deletion at base pair 117 in the tcdC based on microarray and PCR amplification. We compared the performance of the Verigene (R) CDF test to that of two enzyme immunoassays, C. DIFF QUIK CHEK COMPLETE and X/Pect Toxin A/B, using 118 specimens. We found overall concordance rates of 81.4% and 78.8% between C. DIFF QUIK CHEK COMPLETE and Verigene (R) CDF test, and X/Pect Toxin A/B and Verigene (R) CDF test. The Verigene (R) CDF test showed the highest sensitivity (93.9%)and had a specificity of 96.5%. The sensitivity and specificity were respectively 45.5 and 94.1% for C. DIFF QUIK CHEK COMPLETE and 27.3 and 100.0% for X/Pect Toxin A/B. These results indicated that the Verigene (R) CDF test was highly accurate for the detection of C. difficile toxin in fecal specimens and supported its use in daily diagnostic practice. (C) 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:674 / 677
页数:4
相关论文
共 26 条
  • [1] Diagnosis and Treatment of Clostridium difficile in Adults A Systematic Review
    Bagdasarian, Natasha
    Rao, Krishna
    Malani, Preeti N.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (04): : 398 - 408
  • [2] Multicenter Evaluation of the Verigene Clostridium difficile Nucleic Acid Assay
    Carroll, Karen C.
    Buchan, Blake W.
    Tan, Sokha
    Stamper, Paul D.
    Riebe, Katherine M.
    Pancholi, Preeti
    Kelly, Cheryl
    Rao, Arundhati
    Fader, Robert
    Cavagnolo, Robert
    Watson, Wendy
    Goering, Richard V.
    Trevino, Ernest A.
    Weissfeld, Alice S.
    Ledeboer, Nathan A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (12) : 4120 - 4125
  • [3] Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
    Cohen, Stuart H.
    Gerding, Dale N.
    Johnson, Stuart
    Kelly, Ciaran P.
    Loo, Vivian G.
    McDonald, L. Clifford
    Pepin, Jacques
    Wilcox, Mark H.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) : 431 - 455
  • [4] European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection
    Debast, S. B.
    Bauer, M. P.
    Kuijper, E. J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 1 - 26
  • [5] Diagnosis and Management of Clostridium difficile Infection
    Dupont, Herbert L.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (10) : 1216 - 1223
  • [6] Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile
    Gilbreath, Jeremy J.
    Verma, Punam
    Abbott, April N.
    Butler-Wu, Susan M.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 80 (01) : 13 - 18
  • [7] Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile
    Goldenberg, S. D.
    Cliff, P. R.
    Smith, S.
    Milner, M.
    French, G. L.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2010, 74 (01) : 48 - 54
  • [8] Comparison of testing approaches for Clostridium difficile infection at a large community hospital
    Grein, J. D.
    Ochner, M.
    Hoang, H.
    Jin, A.
    Morgan, M. A.
    Murthy, A. R.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (01) : 65 - 69
  • [9] Outcome of colectomy for Clostridium difficile colitis:: a plea for early surgical management
    Hall, Jason F.
    Berger, David
    [J]. AMERICAN JOURNAL OF SURGERY, 2008, 196 (03) : 384 - 388
  • [10] A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients
    Iwashima, Yasuhito
    Nakamura, Atsushi
    Kato, Haru
    Kato, Hideaki
    Wakimoto, Yukio
    Wakiyama, Naoki
    Kaji, Chiharu
    Ueda, Ryuzo
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (05) : 329 - 333